The competition between the world's superpowers is hitting Complete Genomics, whose employees, some in white lab coats stitched with U.S. flag arm patches, spin samples in test tubes and huddle around computers in San Jose. Its founder and chief scientific officer said he's frustrated that geopolitics is interfering with science.
"It's just a loss for the research and for the industry," Radoje Drmanac said.
The U.S. House overwhelmingly passed the BIOSECURE Act, which cites national security in preventing federal money from benefiting Complete Genomics and four other companies linked to China. They work with U.S. drugmakers to develop new medications or help doctors diagnose diseases.
It is part of a sweeping package of bills aimed at countering China's influence and power, especially in technology, that Congress largely backed last week. The biotech measure, which cleared the House with a 306-81 vote, now heads to the Senate.
Supporters say the legislation is necessary to protect Americans' health care data, reduce reliance on China in the medical supply chain and ensure the U.S. gains an edge in the biotech field, which both countries call crucial to their economy and security.
Opponents say the bill, which would ban China-linked companies from working with firms that receive U.S. government money, would delay clinical trials and hinder development of new drugs, raise costs for medications and hurt innovation.
Rep. Brad Wenstrup, an Ohio Republican and the bill's sponsor, said House approval was the first step in protecting Americans' genetic data and reversing the trend of relying on Beijing for gene testing and basic medical supplies.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
AI Home
THE NEXT FRONTIER FOR APPLE INTELLIGENCE, INTERACTION, AND AUTOMATION
Watch
SERIES 10 & ULTRA 2: REFRESHING THE LINEUP WITH NEW FINISHES & BOLD COLORS
Mac mini
SMALL IN SIZE, POWERFUL, AND ENGINEERED FOR APPLE INTELLIGENCE
iMac M4 INTRODUCING THE FIRST APPLE DESKTOP READY FOR ADVANCED AI
Apple has taken another step towards revolutionizing the world of personal computing with the launch of its latest iMac.
MacBook Pro M4 UNMATCHED AI PERFORMANCE THROUGH A NEW STUNNING XDR DISPLAY
Apple has launched its latest lineup featuring the cutting-edge M4 chip family and the all-new Apple Intelligence system.
New-Gen iPads
2024 AIR AND PRO LINES BRING IDEAS TO LIFE LIKE NEVER BEFORE
Assistance A NEW PRODUCTIVITY ERA BEGINS FOR THE ENTIRE APPLE ECOSYSTEM
As Apple continues to lead in hardware-software integration, the debut of Apple Intelligence reinforces its commitment to offering an AI experience unique to its ecosystem, one that aligns with the company’s ethos of privacy and ease of use.
NVIDIA®
THE BREAKTHROUGHS BEHIND THE LATEST AI HARDWARE
2025 SCALING NEW HEIGHTS IN PROCESSING POWER
Over the past few years, Apple has reshaped nearly every part of its ecosystem, from the hardware to the software, to push the boundaries of technology.
iPad mini - AI-READY DESIGN: THE A17 CHIP POWERHOUSE IN A COMPACT SIZE
Technology continues to shrink in size yet grow in capability, and the new iPad mini is no exception. The robust tool was designed to meet the demands of both personal and professional users.